Vx-950 and Rabeprazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vx-950 (telaprevir) and Rabeprazole (rabeprazole sodium). Common drug interactions include anaemia among females and drug eruption among males.

The phase IV clinical study analyzes what interactions people have when they take Vx-950 and Rabeprazole. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Vx-950?

Vx-950 has active ingredients of telaprevir. eHealthMe is studying from 9,465 Vx-950 users. Check the latest studies of Vx-950.

What is Rabeprazole?

Rabeprazole has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 31,689 Rabeprazole users. Check the latest studies of Rabeprazole.

On Jul, 04, 2026

12 people who take Vx-950 and Rabeprazole together, and have interactions are studied.

Vx-950 and Rabeprazole drug interactions.

What are the common drug interactions of Vx-950 and Rabeprazole, by gender? *:

female:

Anaemia (lack of blood)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Loss of consciousness
Blood creatinine increased
Blood uric acid increased
Brain abscess
Hypokalaemia (low potassium)
Pancreatitis acute (sudden inflammation of pancreas)
Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)
Acute myocardial infarction (acute heart attack)

male:

Drug eruption (adverse drug reaction of the skin)
Nausea (feeling of having an urge to vomit)
Anaemia (lack of blood)
Cellulitis (infection under the skin)
Erythema multiforme (a type of hypersensitivity reaction)
Iron deficiency anaemia
Mallory-weiss syndrome (gastro-oesophageal laceration syndrome refers to bleeding from tears)
Skin disorder (skin disease)
White blood cell count decreased

What are the common drug interactions of Vx-950 and Rabeprazole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Nausea (feeling of having an urge to vomit)
Drug eruption (adverse drug reaction of the skin)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Blood creatine phosphokinase increased
Crying
Disturbance in social behaviour
Drug ineffective
Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
Dyspepsia (indigestion)
Emotional disorder

50-59:

n/a

60+:

Anaemia (lack of blood)
Loss of consciousness
Cellulitis (infection under the skin)
Drug eruption (adverse drug reaction of the skin)
Iron deficiency anaemia
Mallory-weiss syndrome (gastro-oesophageal laceration syndrome refers to bleeding from tears)
Pneumonia
Skin disorder (skin disease)
White blood cell count decreased
Blood creatinine increased

What are the existing conditions these people have? *

Hepatitis C: 8 people, 66.67%
Abdominal Discomfort: 3 people, 25.00%
Nausea (feeling of having an urge to vomit): 2 people, 16.67%
Stress And Anxiety: 1 person, 8.33%
Sleep Disorder: 1 person, 8.33%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 8.33%
Rashes (redness): 1 person, 8.33%
Osteoporosis (bones weak and more likely to break): 1 person, 8.33%
Migraine (headache): 1 person, 8.33%
Insomnia (sleeplessness): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Vx-950 and Rabeprazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously